Takeda has finished enrolling 20,100 children for a massive phase 3 dengue vaccine study.
After successfully shepherding a Zika vaccine candidate into the clinic before any other developer, Inovio Pharmaceuticals is amping up its efforts in HIV.
Sanofi Pasteur agreed to pay more than $19.8 million to settle allegations that it overcharged the Department of Veterans Affairs for its products.
About 150 parents turned out to an anti-vaccine rally in Washington, D.C., on Friday. Not a new phenomenon, vaccine opposition may have gained steam with…
The NIH's Zika vaccine will move into phase 2 testing, officials said Friday. Despite the president's threats of spending cuts, this project is fully…
Israeli biotech BiondVax is looking toward the day when its universal flu vaccine will be commercially available and has snagged some government help to…
Prompts on electronic health records could make a big difference in flu vaccination rates.
Even as Pfizer’s vaccine outfit suffers a painful Prevnar 13 slowdown around the world, the group may soon get a boost in Europe.
A rotavirus vaccine candidate showed better efficacy than Merck’s and GlaxoSmithKline’s approved vaccines in a late-stage trial.
After taking a beating over a proposed Zika vaccine license from the U.S. Army, Sanofi is hitting back.